![Harry Råstedt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Harry Råstedt is currently working as a Director at Abera Bioscience AB since 2024.
Previously, he worked as the Head-Vaccines at GlaxoSmithKline AB and as the Vice President & General Manager at GSK Vaccines GmbH.
Actieve functies van Harry Råstedt
| Bedrijven | Functie | Begin |
|---|---|---|
| ABERA BIOSCIENCE AB | Directeur/Bestuurslid | 12-06-2024 |
Eerdere bekende functies van Harry Råstedt
| Bedrijven | Functie | Einde |
|---|---|---|
GlaxoSmithkline AB
 GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
GSK Vaccines GmbH
 GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
GlaxoSmithkline AB
GlaxoSmithkline AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Vaccines GmbH
GSK Vaccines GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Abera Bioscience AB
 Abera Bioscience AB BiotechnologyHealth Technology Operates as biotechnology company that develops bacterial-based platforms for delivery of vaccines and drugs | Health Technology |
